Market Size of France Contraceptive Devices Industry
Study Period | 2021 - 2029 |
Base Year For Estimation | 2023 |
Market Size (2024) | USD 458.16 Million |
Market Size (2029) | USD 624.78 Million |
CAGR (2024 - 2029) | 6.40 % |
Market Concentration | Medium |
Major Players*Disclaimer: Major Players sorted in no particular order |
France Contraceptive Devices Market Analysis
The France Contraceptive Devices Market size is estimated at USD 458.16 million in 2024, and is expected to reach USD 624.78 million by 2029, growing at a CAGR of 6.40% during the forecast period (2024-2029).
The pandemic adversely impacted the contraceptive devices market in France. For instance, as per the study published in April 2022, by the National Library of Medicine, the dispensing of contraceptives in France was remarkably low during the COVID-19 pandemic. Prescriptions for long-acting contraceptive use and women under 25 years were the most substantially impacted. Dispensing of emergency contraceptives (EC) and intrauterine contraceptives decreased more substantially during the first lockdown and then increased moderately at the end of 2020 and in 2021. Hence, with the resumption of services due to the decrease in COVID-19 cases, the market started to recover and is expected to maintain its growth over the forecast period.
The increasing awareness about sexually transmitted diseases (STDs), the rising rate of unintended pregnancies, and the rise in government initiatives are the major factors driving the market. For instance, in November 2021, a report published by the WHO stated that sexual intercourse is the second most commonly reported mode of transmission of STDs in the European Union, accounting for 29.7% of all HIV diagnoses. The highest proportions were observed in France (53.0%) in 2021. Thus, the high burden of STDs in France than other European countries is expected to increase the demand for contraceptive devices, which is expected to boost the market's growth over the forecast period.
Similarly, the report published in October 2021 by the HPV World stated that the prevalence of HPV 16 and 18 among adult women with normal cytology is 4.7%, with low-grade cervical lesions is 26.3%, with high-grade cervical lesions is 60.6%, and with cervical cancer is 75.6%. Such instances indicate that the demand for contraceptive devices may increase. Thereby, considerable market growth is anticipated over the forecast period.
However, side effects associated with the use of contraceptive devices may likely restrain the market over the forecast period.
France Contraceptive Devices Industry Segmentation
As per the scope of the report, contraceptive devices are barriers that attempt to prevent pregnancy by physically preventing sperm from entering the uterus. Contraception is more commonly known as fertility, and birth control is described as the method used to avoid pregnancy. They include male condoms, female condoms, cervical caps, diaphragms, and contraceptive sponges with spermicide.
The French contraceptive devices market is segmented by product type (condoms, diaphragms, cervical caps, sponges, vaginal rings, intra uterine devices (IUD), and other product types) and gender (male and female). The report offers the value (in USD million) for the above segments.
By Product Type | |
Condoms | |
Diaphragms | |
Cervical Caps | |
Sponges | |
Vaginal Rings | |
Intra Uterine Device (IUD) | |
Other Product Types |
By Gender | |
Male | |
Female |
France Contraceptive Devices Market Size Summary
The French contraceptive devices market is poised for significant growth over the forecast period, driven by increasing awareness of sexually transmitted diseases and a rising rate of unintended pregnancies. Government initiatives, such as providing free contraception to young women and promoting safe sex practices, are further propelling market expansion. The market experienced a downturn during the COVID-19 pandemic, with a notable decline in contraceptive prescriptions, particularly among younger women and for long-acting methods. However, as services resumed and COVID-19 cases decreased, the market began to recover and is expected to continue its upward trajectory.
The demand for condoms and other contraceptive devices is bolstered by the high prevalence of sexually transmitted infections in France, which surpasses that of other European countries. The female segment of the market is anticipated to grow significantly due to increased adoption of contraceptive methods and the need to address unintended pregnancies. Despite potential market restraints from side effects associated with contraceptive use, the overall competitive landscape remains moderately fragmented, with both international and local companies like AbbVie Inc., Bayer Healthcare, and Cooper Surgical Inc. holding notable market shares.
France Contraceptive Devices Market Size - Table of Contents
-
1. MARKET DYNAMICS
-
1.1 Market Overview
-
1.2 Market Drivers
-
1.2.1 Increasing Awareness ÌÇÐÄvlog´«Ã½ Sexually Transmitted Diseases (STDs)
-
1.2.2 Rising Rate of Unintended Pregnancies and Government Initiatives
-
-
1.3 Market Restraints
-
1.3.1 Side Effects Associated with the Use of Contraceptive Devices
-
-
1.4 Porter's Five Forces Analysis
-
1.4.1 Bargaining Power of Suppliers
-
1.4.2 Bargaining Power of Buyers/Consumers
-
1.4.3 Bargaining Power of Suppliers
-
1.4.4 Threat of Substitute Products
-
1.4.5 Intensity of Competitive Rivalry
-
-
-
2. MARKET SEGMENTATION (Market Size by Value - USD mllion)
-
2.1 By Product Type
-
2.1.1 Condoms
-
2.1.2 Diaphragms
-
2.1.3 Cervical Caps
-
2.1.4 Sponges
-
2.1.5 Vaginal Rings
-
2.1.6 Intra Uterine Device (IUD)
-
2.1.7 Other Product Types
-
-
2.2 By Gender
-
2.2.1 Male
-
2.2.2 Female
-
-
France Contraceptive Devices Market Size FAQs
How big is the France Contraceptive Devices Market?
The France Contraceptive Devices Market size is expected to reach USD 458.16 million in 2024 and grow at a CAGR of 6.40% to reach USD 624.78 million by 2029.
What is the current France Contraceptive Devices Market size?
In 2024, the France Contraceptive Devices Market size is expected to reach USD 458.16 million.